Global Genome Sequencing Market, By Nucleotide Sequenced (DNA v/s RNA), By Technique (Next Generation Sequencing, PCR, Microarray Technology, Others), By Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Others), By End User (Aca

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,900	111 Pages	TechSci Research	September, 2022	TCSI17382284

Best Price Guarantee
Price	from $4,900
Length	111 Pages
Publisher	TechSci Research
Published Date	September, 2022
SKU	TCSI17382284

Global Genome Sequencing Market, By Nucleotide Sequenced (DNA v/s RNA), By Technique (Next Generation Sequencing, PCR, Microarray Technology, Others), By Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Others), By End User (Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others), By Region Competition Forecast and Opportunities, 2027

Global genome sequencing market is anticipated to grow with an impressive CAGR during the forecast years on the grounds of growing technological advancement in genetic sequencing and bioinformatics. Surge in the demand for the advanced pharmaceuticals and evolving infectious diseases further drive the growth of the global genome sequencing market in the upcoming five years. With consistent supply of financial funds from the government and higher research scope in the technology also supports the growth of the global genome sequencing market in the next five years. Moreover, growing instances of cancer and increasing applications of next generation sequencing in cancer research, the entry of new players and start-ups in the genomics industry further substantiates the growth of the global genome sequencing market in the forecast years.

Genome sequencing is a form of genetic engineering tool that can be defined as the method of identification and analysis of the genetic material found in any living organisms. Sequencing is basically identifying the DNA or RNA mapping sequences to diagnose the function of the translated protein and its effect on the organisms. The genome sequencing helps in identifying the threat or the properties of the evolution of the organisms. The process becomes highly apt for the healthcare processes where identification of the disease causing microorganisms can be carried out and design effective pharmaceutical and therapeutics along with precision medicine to treat these diseases.

Pharmaceutical Evolution Drives Market Growth

Increasing instances of infectious diseases and surge in the demands for the effective vaccinations and pharmaceutical products actively drive the growth of the global genome sequencing market in the upcoming five years. Application of genome sequencing for drug discovery and development increased in the recent years owing to the pandemic conditions caused due to viral infection of COVID-19. Sudden demand for the vaccination and treatment pharmaceuticals and therapeutics further aided to the growth of the global genome sequencing market in the future five years.

Detailed study on the genome (RNA) of the SARS-CoV-2 virus was conducted and multiple market players with the financial aids from the government discovered effective vaccine against the infection. High investments, reliability of the procedure, along with the threat of lost lives due to COVID-19 played major role in the recent developments in the genome sequencing thereby substantiating the growth of the global genome sequencing market in the forecast years. Government authorities like National Institutes for Health in the United States invested USD4435 Million in total human genome project that would be utilized for the further advancement of genome sequencing procedures.

Diagnostic Advances Through Genome Sequencing

Genome sequencing also allows detailed diagnosis of the organisms and their functions. Advancement in the biotechnological procedures and microbiology studies add to the growth of the global genome sequencing market in the upcoming five years. Procedures like next generation sequencing might be expensive but it provides simultaneous analysis of many genomic loci while revealing the exact sequence changes. For the diagnosis of cancer at early stage and to identify the complication of the chronic disease, the process allows clinicians to test many genes of a cancer simultaneously. The process has multiple advantages like ultra-high throughput, scalability, and speed, thus stimulating further demands and substantiating the market growth. The process is also actively utilized in next generation therapeutics development.

Higher prevalence of genetic mutations and environmental factors that play right into evolving the DNA or RNA of the organisms, require highly capable procedures of sequencing such that advancing and evolving genomes could be mapped. Identification of organisms is not only beneficial in case of diseases, but also to map the variants of species alive, thereby academic growth in the sequencing further facilitates the growth of the global genome sequencing market in the upcoming five years.

Market Segmentation

The global genome sequencing market segmentation is based on nucleotide sequenced, technique, application, end user, regional distribution, and competitive landscape. Based on nucleotide sequenced, the market is differentiated between DNA and RNA. By technique, the market is further segmented into next generation sequencing, PCR, microarray technology, and others. Based on application, the market is bifurcated into diagnostics, drug discovery & development, precision medicine, and others. By end user, the market is fragmented into academic & research institutions, pharmaceutical & biotechnology companies, hospitals & clinics, and others. The market analysis also studies the regional segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and Middle East & African region.

Company Profile

Thermo Fisher Scientific, Inc., Ilumina, Inc., QIAGEN N.V., Eurofins Scientific SE, Agilent Technologies, Inc., Oxford Nanopore Technologies Limited, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Abbott Laboratories, Inc., Danaher Corporation, are enlisted in a partial list of major market players of the global genome sequencing market.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2023–2027

Report Scope:

In this report, global genome sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Genome Sequencing Market, By Nucleotide Sequenced:
DNA
RNA
Genome Sequencing Market, By Technique:
Next Generation Sequencing
Polymerase Chain Reaction (PCR)
Microarray Technology
Others
Genome Sequencing Market, By Application:
Diagnostics
Drug Discovery & Development
Precision Medicine
Others
Genome Sequencing Market, By End User:
Academic & Research Institutions
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Others
Genome Sequencing Market, By Region:
North America
United States
Mexico
Canada
Asia-Pacific
China
India
Japan
South Korea
Australia
Europe
France
Germany
United Kingdom
Italy
Spain
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global genome sequencing market.

Company Information

Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Genome Sequencing Market
5. Voice of Customer: 5.1. Factors Contributing to Demand for Genome Sequencing; 5.2. Source of Information; 5.3. Commonly Sequenced Nucleotides; 5.4. Preference, By Technique; 5.5. Demand, By Application; 5.6. Brand Awareness
6. Global Genome Sequencing Market Outlook: 6.1. Market Size & Forecast; 6.1.1. By Value; 6.2. Market Share & Forecast; 6.2.1. By Nucleotide Sequenced (DNA v/s RNA); 6.2.2. By Technique (Next Generation Sequencing, PCR, Microarray Technology, Others); 6.2.3. By Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Others); 6.2.4. By End User (Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others); 6.2.5. By Company (2021); 6.2.6. By Region; 6.3. Product Market Map
7. North America Genome Sequencing Market Outlook: 7.1. Market Size & Forecast; 7.1.1. By Value; 7.2. Market Share & Forecast; 7.2.1. By Nucleotide Sequenced; 7.2.2. By Technique; 7.2.3. By Application; 7.2.4. By End User; 7.2.5. By Country; 7.3. North America: Country Analysis; 7.3.1. United States Genome Sequencing Market Outlook; 7.3.1.1. Market Size & Forecast; 7.3.1.1.1. By Value; 7.3.1.2. Market Share & Forecast; 7.3.1.2.1. By Nucleotide Sequenced; 7.3.1.2.2. By Technique; 7.3.1.2.3. By Application; 7.3.1.2.4. By End User; 7.3.2. Mexico Genome Sequencing Market Outlook; 7.3.2.1. Market Size & Forecast; 7.3.2.1.1. By Value; 7.3.2.2. Market Share & Forecast; 7.3.2.2.1. By Nucleotide Sequenced; 7.3.2.2.2. By Technique; 7.3.2.2.3. By Application; 7.3.2.2.4. By End User; 7.3.3. Canada Genome Sequencing Market Outlook; 7.3.3.1. Market Size & Forecast; 7.3.3.1.1. By Value; 7.3.3.2. Market Share & Forecast; 7.3.3.2.1. By Nucleotide Sequenced; 7.3.3.2.2. By Technique; 7.3.3.2.3. By Application; 7.3.3.2.4. By End User
8. Europe Genome Sequencing Market Outlook: 8.1. Market Size & Forecast; 8.1.1. By Value; 8.2. Market Share & Forecast; 8.2.1. By Nucleotide Sequenced; 8.2.2. By Technique; 8.2.3. By Application; 8.2.4. By End User; 8.2.5. By Country; 8.3. Europe: Country Analysis; 8.3.1. France Genome Sequencing Market Outlook; 8.3.1.1. Market Size & Forecast; 8.3.1.1.1. By Value; 8.3.1.2. Market Share & Forecast; 8.3.1.2.1. By Nucleotide Sequenced; 8.3.1.2.2. By Technique; 8.3.1.2.3. By Application; 8.3.1.2.4. By End User; 8.3.2. Germany Genome Sequencing Market Outlook; 8.3.2.1. Market Size & Forecast; 8.3.2.1.1. By Value; 8.3.2.2. Market Share & Forecast; 8.3.2.2.1. By Nucleotide Sequenced; 8.3.2.2.2. By Technique; 8.3.2.2.3. By Application; 8.3.2.2.4. By End User; 8.3.3. United Kingdom Genome Sequencing Market Outlook; 8.3.3.1. Market Size & Forecast; 8.3.3.1.1. By Value; 8.3.3.2. Market Share & Forecast; 8.3.3.2.1. By Nucleotide Sequenced; 8.3.3.2.2. By Technique; 8.3.3.2.3. By Application; 8.3.3.2.4. By End User; 8.3.4. Italy Genome Sequencing Market Outlook; 8.3.4.1. Market Size & Forecast; 8.3.4.1.1. By Value; 8.3.4.2. Market Share & Forecast; 8.3.4.2.1. By Nucleotide Sequenced; 8.3.4.2.2. By Technique; 8.3.4.2.3. By Application; 8.3.4.2.4. By End User; 8.3.5. Spain Genome Sequencing Market Outlook; 8.3.5.1. Market Size & Forecast; 8.3.5.1.1. By Value; 8.3.5.2. Market Share & Forecast; 8.3.5.2.1. By Nucleotide Sequenced; 8.3.5.2.2. By Technique; 8.3.5.2.3. By Application; 8.3.5.2.4. By End User
9. Asia-Pacific Genome Sequencing Market Outlook: 9.1. Market Size & Forecast; 9.1.1. By Value; 9.2. Market Share & Forecast; 9.2.1. By Nucleotide Sequenced; 9.2.2. By Technique; 9.2.3. By Application; 9.2.4. By End User; 9.2.5. By Country; 9.3. Asia-Pacific: Country Analysis; 9.3.1. China Genome Sequencing Market Outlook; 9.3.1.1. Market Size & Forecast; 9.3.1.1.1. By Value; 9.3.1.2. Market Share & Forecast; 9.3.1.2.1. By Nucleotide Sequenced; 9.3.1.2.2. By Technique; 9.3.1.2.3. By Application; 9.3.1.2.4. By End User; 9.3.2. India Genome Sequencing Market Outlook; 9.3.2.1. Market Size & Forecast; 9.3.2.1.1. By Value; 9.3.2.2. Market Share & Forecast; 9.3.2.2.1. By Nucleotide Sequenced; 9.3.2.2.2. By Technique; 9.3.2.2.3. By Application; 9.3.2.2.4. By End User; 9.3.3. South Korea Genome Sequencing Market Outlook; 9.3.3.1. Market Size & Forecast; 9.3.3.1.1. By Value; 9.3.3.2. Market Share & Forecast; 9.3.3.2.1. By Nucleotide Sequenced; 9.3.3.2.2. By Technique; 9.3.3.2.3. By Application; 9.3.3.2.4. By End User; 9.3.4. Japan Genome Sequencing Market Outlook; 9.3.4.1. Market Size & Forecast; 9.3.4.1.1. By Value; 9.3.4.2. Market Share & Forecast; 9.3.4.2.1. By Nucleotide Sequenced; 9.3.4.2.2. By Technique; 9.3.4.2.3. By Application; 9.3.4.2.4. By End User; 9.3.5. Australia Genome Sequencing Market Outlook; 9.3.5.1. Market Size & Forecast; 9.3.5.1.1. By Value; 9.3.5.2. Market Share & Forecast; 9.3.5.2.1. By Nucleotide Sequenced; 9.3.5.2.2. By Technique; 9.3.5.2.3. By Application; 9.3.5.2.4. By End User
10. South America Genome Sequencing Market Outlook: 10.1. Market Size & Forecast; 10.1.1. By Value; 10.2. Market Share & Forecast; 10.2.1. By Nucleotide Sequenced; 10.2.2. By Technique; 10.2.3. By Application; 10.2.4. By End User; 10.2.5. By Country; 10.3. South America: Country Analysis; 10.3.1. Brazil Genome Sequencing Market Outlook; 10.3.1.1. Market Size & Forecast; 10.3.1.1.1. By Value; 10.3.1.2. Market Share & Forecast; 10.3.1.2.1. By Nucleotide Sequenced; 10.3.1.2.2. By Technique; 10.3.1.2.3. By Application; 10.3.1.2.4. By End User; 10.3.2. Argentina Genome Sequencing Market Outlook; 10.3.2.1. Market Size & Forecast; 10.3.2.1.1. By Value; 10.3.2.2. Market Share & Forecast; 10.3.2.2.1. By Nucleotide Sequenced; 10.3.2.2.2. By Technique; 10.3.2.2.3. By Application; 10.3.2.2.4. By End User; 10.3.3. Colombia Genome Sequencing Market Outlook; 10.3.3.1. Market Size & Forecast; 10.3.3.1.1. By Value; 10.3.3.2. Market Share & Forecast; 10.3.3.2.1. By Nucleotide Sequenced; 10.3.3.2.2. By Technique; 10.3.3.2.3. By Application; 10.3.3.2.4. By End User
11. Middle East and Africa Genome Sequencing Market Outlook: 11.1. Market Size & Forecast; 11.1.1. By Value; 11.2. Market Share & Forecast; 11.2.1. By Nucleotide Sequenced; 11.2.2. By Technique; 11.2.3. By Application; 11.2.4. By End User; 11.2.5. By Country; 11.3. MEA: Country Analysis; 11.3.1. South Africa Genome Sequencing Market Outlook; 11.3.1.1. Market Size & Forecast; 11.3.1.1.1. By Value; 11.3.1.2. Market Share & Forecast; 11.3.1.2.1. By Nucleotide Sequenced; 11.3.1.2.2. By Technique; 11.3.1.2.3. By Application; 11.3.1.2.4. By End User; 11.3.2. Saudi Arabia Genome Sequencing Market Outlook; 11.3.2.1. Market Size & Forecast; 11.3.2.1.1. By Value; 11.3.2.2. Market Share & Forecast; 11.3.2.2.1. By Nucleotide Sequenced; 11.3.2.2.2. By Technique; 11.3.2.2.3. By Application; 11.3.2.2.4. By End User; 11.3.3. UAE Genome Sequencing Market Outlook; 11.3.3.1. Market Size & Forecast; 11.3.3.1.1. By Value; 11.3.3.2. Market Share & Forecast; 11.3.3.2.1. By Nucleotide Sequenced; 11.3.3.2.2. By Technique; 11.3.3.2.3. By Application; 11.3.3.2.4. By End User
12. Market Dynamics: 12.1. Drivers; 12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape: 14.1. Company Profiles; 14.1.1. Company Details; 14.1.2. Financials (As reported); 14.1.3. Key Market Focus and Geographical Presence; 14.1.4. Pricing of Target Products; 14.1.5. Market positioning; 14.2. Thermo Fisher Scientific, Inc.; 14.3. Ilumina, Inc.; 14.4. QIAGEN N.V.; 14.5. Eurofins Scientific SE; 14.6. Agilent Technologies, Inc.; 14.7. Oxford Nanopore Technologies Limited; 14.8. F. Hoffmann-La Roche AG; 14.9. Bio-Rad Laboratories, Inc.; 14.10. Abbott Laboratories, Inc.; 14.11. Danaher Corporation
15. Strategic Recommendations: (Note: The companies list can be customized based on the client requirements.)

Agrigenomics Market Forecasts to 2030 – Global Analysis By Sequencer Type (Sanger Sequencing, Illumina Hi Seq Family, Pacbio Sequencers, Solid Sequencers and Other Sequencer Types), Objective (DNA Extraction & Purification, DNA/RNA Sequencing, Genotyping, Gene Expression Profiling, Marker-assisted Selection, GMO/Trait Purity Testing and Other Objectives), Technology (Real-Time PCR (qPCR), Microarrays, Next Generation Sequencing, Capillary Electrophoresis and Other Technologies), Application and by Geography

February, 2024 | Published by: Stratistics Market Research Consulting | USD $4,150
Gene Expression Analysis Market by Product (Reagents, Enzymes, kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & development, clinical diagnostics), End User - Global Forecast to 2029

March, 2024 | Published by: MarketsandMarkets | USD $4,950
Agrigenomics Market by Sequencer Type (Illumina Hi Seq Family, PacBio Sequencers, Sanger Sequencing), Function (Next-Generation Genotyping, Targeted Sequencing, Whole-Genome Sequencing), Application - Global Forecast 2024-2030

January, 2024 | Published by: 360iResearch | USD $4,749
Agrigenomics Market Analysis and Forecast to 2031: By Objective (Genotyping, DNA/RNA Sequencing, Gene Expression Profiling, and Others), Sequencer Type(Solid Sequencers, Sanger Sequencing, and Others), Application (Crops, and Livestock), and Region

April, 2023 | Published by: Global Insight Services | USD $4,750
United States Genetic Testing Market By Technique (PCR, DNA Sequencing, Microarrays, Others), By Application (Cardiology, Oncology, Pharmacogenomics, Cognitive Dysfunction, Others), By Region, Competition, Forecast and& Opportunities, 2019-2029F

August, 2024 | Published by: TechSci Research | USD $3,500
RNA Analysis Market by Product (Reagents, Instruments, Software, Services), Technology (PCR, Sequencing, Microarrays, RNA Interference), Application (Drug Discovery, Clinical Diagnostics), End User (Pharma, Biotech, CROs), Region - Global Forecast to 2028

July, 2023 | Published by: MarketsandMarkets | USD $4,950

PDF E-mail From Publisher:	$4,900
Multi User License Fulfilled by Publisher:	$5,900
Global Site License Fulfilled by Publisher:	$8,900

Global Genome Sequencing Market, By Nucleotide Sequenced (DNA v/s RNA), By Technique (Next Generation Sequencing, PCR, Microarray Technology, Others), By Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Others), By End User (Aca

Research Assistance

Other tasks

Global Genome Sequencing Market, By Nucleotide Sequenced (DNA v/s RNA), By Technique (Next Generation Sequencing, PCR, Microarray Technology, Others), By Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Others), By End User (Aca

Gene Expression Analysis Market by Product (Reagents, Enzymes, kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & development, clinical diagnostics), End User - Global Forecast to 2029

Agrigenomics Market by Sequencer Type (Illumina Hi Seq Family, PacBio Sequencers, Sanger Sequencing), Function (Next-Generation Genotyping, Targeted Sequencing, Whole-Genome Sequencing), Application - Global Forecast 2024-2030

Agrigenomics Market Analysis and Forecast to 2031: By Objective (Genotyping, DNA/RNA Sequencing, Gene Expression Profiling, and Others), Sequencer Type(Solid Sequencers, Sanger Sequencing, and Others), Application (Crops, and Livestock), and Region

United States Genetic Testing Market By Technique (PCR, DNA Sequencing, Microarrays, Others), By Application (Cardiology, Oncology, Pharmacogenomics, Cognitive Dysfunction, Others), By Region, Competition, Forecast and& Opportunities, 2019-2029F

RNA Analysis Market by Product (Reagents, Instruments, Software, Services), Technology (PCR, Sequencing, Microarrays, RNA Interference), Application (Drug Discovery, Clinical Diagnostics), End User (Pharma, Biotech, CROs), Region - Global Forecast to 2028

Research Assistance

Other tasks